Clinical and biological characteristics of breast cancer

Journal of B.U.ON.

Volumn 15, Issue 4, 2010, Pages 660-667

  Kocic, Biljana ^a,b   Filipovic, S ^a,c   Petrovic, B ^a,b   Mijalkovic, D ^d   Rancic, N ^a,b   Poultsidi, A ^e  

^a UNIVERSITY OF NI   (Serbia)

^b Institute of Public Health Nis   (Serbia)

^c Clinic of Oncology Nis   (Serbia)

^d Health Centre   (Serbia)

^e UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Biological characteristics; Breast carcinoma; Clinical characteristics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRASTUZUMAB;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHI SQUARE TEST; EARLY DIAGNOSIS; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIMARY TUMOR; PROBABILITY; STUDENT T TEST;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 78651384016     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Smith RA, Saslow D, Sawyer KA et al. American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 2003; 53: 141-169.
2. Jovicevic-Bekic A. Epidemiology of breast cancer and breast cancer risk factors. In: Sobic V, Vuckovic-Dekic Lj, Neskovic-Konstantinovic Z (Eds): State-of-the-art in breast cancer diagnosis and treatment. Serbian Academy of Sciences and Arts and Institute of Oncology and Radiology of Serbia; Belgrade, Serbia, 2005 (in Serbian).
3. Institute of Public Health of Serbia. Cancer incidence and mortality in Central Serbia 2003. Cancer register of central Serbia: Report number 5 ; Belgrade, 2006.
4. Hospital Cancer Registry report 2003. Department of Epidemiology and Prevention, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia, 2004 (in Serbian).
5. Miljus D, Vukicevic A, Ivkovic S. Cancer incidence and mortality in Central Serbia 2004. Cancer register of central Serbia. Institute of Public Health of Serbia, Belgrade, 2008.
6. Theriault RL, Sellin RV. Estrogen-replacement therapy in younger women with breast cancer. J Natl Cancer Inst Monogr 1994; 16: 149-152.
7. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol 2005; 15/10: 773-780.
8. Shahriari AA, Ghavamzadeh A, Amiri N, Farnia V, Samadzadeh S, Malekniazi A. Clinical, biological and pathological characteristics of breast cancer patients at the Taleghani University hospital in Kermanshah, Iran. IJHOBMT 2005; 2: 6-11.
9. Molino A, Giovannini M, Auriemma A et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 2006; 32: 1-8.
10. Alberg AJ, Singh S. Epidemiology of breast cancer in older women: implications for future healthcare. Drug Aging 2001; 18: 761-772.
11. Franceschi S, La Vecchia C. Cancer epidemiology in the elderly. Crit Rev Oncol Hematol 2001; 39: 219-226.
12. Mathieu MC, Rouzier R, Llombart-Cussac A et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 2004; 40: 342-351.
13. Harris JR, Lippman ME, Morrow M, Osbourne CK (Eds). Diseases of the breast (3rd Edn). Philadelphia, PA, Lippincott Williams and Wilkins, 2004, pp 675-682.
14. Guidelines for the Management of Symptomatic Breast Disease. Eur J Surg Oncol 2005; 31: S1-521.
15. Badoual C, Maruani A, Ghorra C, Lebas P, Avigdor S, Michenet P. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions. The Breast 2005; 14: 22-27.
16. Li Ci, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinoma by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 2005; 14: 1008-1011.
17. Li Ci, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 2002; 75: 259-268.
18. Kotari AS, Fentiman IS. Breast cancer in young women. Int J Clin Pract 2002; 56: 184-187.
19. Chariyalertsak S, Ruangvejvovachi P. Immunohistochemical detection of estrogen and progesterone receptors in primary breast cancer. Asian Pac J Allergy Immunol 1998; 16: 161-166.
20. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: a study of 798 tumours. The Breast 2000; 9: 267-270.
21. Barnes DM, Millis RR. Oestrogen receptors: the history, the relevance and the methods of evaluation. In: Kirkham N, Lemoine NR (Eds): Progress in Pathology. Churchill Livingstone, Edinburgh, 1995, pp 89-114.
22. Ros JS, Fletcher JA, Linette GP et al. The HER2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy. The Oncologist 2003; 8: 307-325.
23. Konecny, Pauletti G, Pegram M et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst 2003; 95: 142-153. (Pubitemid 36193263)